ACSL4 and cardiac hypertrophy: In addition, TAC increased the levels of all three markers of cardiac hypertrophy (namely, β-MHC, RCAN1.4, and ANF) in the Acsl4 F/F mice, and this increase was virtually eliminated in TAC-operated Acsl4 KO mice (Fig. 3i, j).